Login

Switch On Your HIV Smarts.

For people with drug resistant HIV, monoclonal antibody shows promise as “rescue” therapy

For people with drug resistant HIV, monoclonal antibody shows promise as “rescue” therapy

, by Liz Highleyman

A monoclonal antibody shows promise for people living with HIV who are “left behind,” with few HIV treatment options, when current antiretrovirals fail from drug resistance. Read More

Too many HIV meds, a small-town judge, and 10 days in jail

Too many HIV meds, a small-town judge, and 10 days in jail

, by David Duran

David Duran tackles the complicated issue of polypharmacy, and the problems caused by taking too many meds to keep track of. Read More

8 things to know about lipodystrophy and HIV

8 things to know about lipodystrophy and HIV

, by Emily Newman

What is lipodystrophy? Dr. Steven Grinspoon offers some insight into what causes this confusing condition, and what to do about it. Read More

Hey healthcare providers of young gay/queer men: Are you telling them about PrEP?

Hey healthcare providers of young gay/queer men: Are you telling them about PrEP?

, by Pierre-Cédric Crouch, PhD, ANP-BC

Most young gay men of color know of PrEP, but they aren’t accessing it. What can health care providers for young gay men do to change this? Read More

Ask A Pharmacist: With a new tenofovir, should you switch to Descovy, Genvoya or Odefsey?

Ask A Pharmacist: With a new tenofovir, should you switch to Descovy, Genvoya or Odefsey?

, by Jennifer Cocohoba, PharmD, AAHIVE

Pharmacist Jen Cocohoba gives us the low down on what to consider if you’re interested in asking your health care provider about switching to treatments with the newest version of tenofovir. Read More